Holen Sie sich die Stockscreener-App
0.8399
2.55%
-0.022
Handel nachbörslich:
.82
-0.0199
-2.37%
Schlusskurs vom Vortag:
$0.8619
Offen:
$0.86
24-Stunden-Volumen:
1.19M
Relative Volume:
1.26
Marktkapitalisierung:
$108.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.91M
KGV:
-3.8177
EPS:
-0.22
Netto-Cashflow:
$-19.57M
1W Leistung:
-0.24%
1M Leistung:
-2.54%
6M Leistung:
-9.81%
1J Leistung:
-40.43%
1-Tages-Spanne:
$0.8068
$0.8629
1-Wochen-Bereich:
$0.8068
$0.8909
52-Wochen-Spanne:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Firmenname
Atossa Therapeutics Inc
Sektor
Branche
Telefon
206.588.0256
Adresse
10202 5TH AVENUE NE, SEATTLE, WA
Vergleichen Sie ATOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.8399 | 111.33M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-01-26 | Eingeleitet | Maxim Group | Buy |
Atossa Therapeutics Inc Aktie (ATOS) Neueste Nachrichten
Is Atossa Therapeutics Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia
Atossa Therapeutics Inc. Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
What analysts say about Atossa Therapeutics Inc. stockFree Market Volatility Navigation Tips - Autocar Professional
Does Atossa Therapeutics Inc. stock pay reliable dividendsFree Consultation - jammulinksnews.com
Why Atossa Therapeutics Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser
Will Atossa Therapeutics Inc. stock split in the near futureDynamic investment growth - jammulinksnews.com
How Atossa Therapeutics Inc. stock reacts to Fed policy changesStrongest growth potential - jammulinksnews.com
What drives Atossa Therapeutics Inc. stock priceExceptional profit potential - Autocar Professional
Should I buy Atossa Therapeutics Inc. stock before earningsHigh Win Rate Stock Ideas - Newser
How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser
What makes Atossa Therapeutics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser
Ascendiant Lifts Atossa Therapeutics, Inc. (ATOS) Target Citing Strong Liquidity - MSN
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World
Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World
Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World
Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World
Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):